|
CASP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.379300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.403570E-03 |
| Normal-vs-Stage2 |
9.186000E-01 |
| Normal-vs-Stage3 |
2.568000E-02 |
| Normal-vs-Stage4 |
4.957900E-02 |
| Stage1-vs-Stage2 |
3.844400E-03 |
| Stage1-vs-Stage3 |
3.326600E-01 |
| Stage1-vs-Stage4 |
3.685000E-01 |
| Stage2-vs-Stage3 |
4.796300E-02 |
| Stage2-vs-Stage4 |
8.674000E-02 |
| Stage3-vs-Stage4 |
8.882800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.101500E-03 |
| Normal-vs-AfricanAmerican |
3.482300E-02 |
| Normal-vs-Asian |
1.344700E-03 |
| Caucasian-vs-AfricanAmerican |
9.468200E-01 |
| Caucasian-vs-Asian |
3.033600E-01 |
| AfricanAmerican-vs-Asian |
5.457200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.125840E-02 |
| Normal-vs-Female |
7.938000E-03 |
| Male-vs-Female |
9.876000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.042300E-04 |
| Normal-vs-Age(41-60Yrs) |
2.616200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.173400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.206230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.097830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.535700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.125400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.345200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.858800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.740200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.311000E-01 |
| Classical-VS-Follicular |
3.89300003345028E-09 |
| Classical-VS-Other |
1.300370E-01 |
| Classical-VS-Normal |
6.26519999999964E-05 |
| Tall-VS-Follicular |
4.604500E-03 |
| Tall-VS-Other |
2.925800E-01 |
| Tall-VS-Normal |
2.247800E-02 |
| Follicular-VS-Other |
6.642200E-01 |
| Follicular-VS-Normal |
5.053400E-01 |
| Other-VS-Normal |
8.803800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.275900E-02 |
| Normal-vs-N1 |
5.938200E-02 |
| N0-vs-N1 |
6.306400E-01 |
|
|
